68084-416-21 : NDC 2026 Code

68084-416-21 : Lamivudine And Zidovudine ( Lamivudine And Zidovudine )

Additionally :

You can get information about “68084-416-21” NDC code in 68084-416-21 in HTML format

HTML | 68084-416-21 in TXT (Plain Text) format

TXT | 68084-416-21 in PDF (Portable Document Format)

PDF | 68084-416-21 in XML format

XML formats.

NDC Code : 68084-416-21 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "68084-416-21",
    "PackageDescription": "30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-416-21)  &gt; 1 TABLET, FILM COATED in 1 BLISTER PACK (68084-416-11)",
    "NDC11Code": "68084-0416-21",
    "ProductNDC": "68084-416",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Lamivudine And Zidovudine",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Lamivudine And Zidovudine",
    "DosageFormName": "TABLET, FILM COATED",
    "RouteName": "ORAL",
    "StartMarketingDate": "20140220",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA202418",
    "LabelerName": "American Health Packaging",
    "SubstanceName": "LAMIVUDINE; ZIDOVUDINE",
    "StrengthNumber": "150; 300",
    "StrengthUnit": "mg/1; mg/1",
    "Pharm_Classes": "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Deprecated",
    "LastUpdate": "2015-11-18",
    "PackageNdcExcludeFlag": null,
    "ProductNdcExcludeFlag": null,
    "ListingRecordCertifiedThrough": null,
    "StartMarketingDatePackage": null,
    "EndMarketingDatePackage": null,
    "SamplePackage": null
  }
}